Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.
Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.
Gerald L. LeCarpentier, PhD, of the University of Michigan in Ann Arbor, and colleagues examined the usefulness of a 3D Doppler ultrasound exam to distinguish benign and malignant lesions among women scheduled for a core or excisional biopsy of the breast due to a suspicious breast mass.
Overall, 78 women between the ages of 26 and 70 had the 3D ultrasound and were biopsied. 3D Doppler ultrasound had a sensitivity of 100% in identifying malignant tumors and a specificity of 86% in excluding benign tumors when used in combination with age-based assessment and gray scale visual analysis, the researchers report.
“Using 3D scans promises greater accuracy due to more consistent sampling over the entire tumor,” said LeCarpentier in a statement. “Using speed-weighted 3D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded.”
LeCarpentier GL, Roubidoux MA, Fowlkes JB, et al. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme. Radiology. 2008;249:463-470. DOI:10.1148/radiol.2492060888.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More